Fluid and electrolyte disturbances in critically ill patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J.W. | - |
dc.date.accessioned | 2021-06-18T12:44:26Z | - |
dc.date.available | 2021-06-18T12:44:26Z | - |
dc.date.issued | 2010-12 | - |
dc.identifier.issn | 1738-5997 | - |
dc.identifier.issn | 2092-9935 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/46901 | - |
dc.description.abstract | Disturbances in fluid and electrolytes are among the most common clinical problems encountered in the intensive care unit (ICU). Recent studies have reported that fluid and electrolyte imbalances are associated with increased morbidity and mortality among critically ill patients. To provide optimal care, health care providers should be familiar with the principles and practice of fluid and electrolyte physiology and pathophysiology. Fluid resuscitation should be aimed at restoration of normal hemodynamics and tissue perfusion. Early goal-directed therapy has been shown to be effective in patients with severe sepsis or septic shock. On the other hand, liberal fluid administration is associated with adverse outcomes such as prolonged stay in the ICU, higher cost of care, and increased mortality. Development of hyponatremia in critically ill patients is associated with disturbances in the renal mechanism of urinary dilution. Removal of nonosmotic stimuli for vasopressin secretion, judicious use of hypertonic saline, and close monitoring of plasma and urine electrolytes are essential components of therapy. Hypernatremia is associated with cellular dehydration and central nervous system damage. Water deficit should be corrected with hypotonic fluid, and ongoing water loss should be taken into account. Cardiac manifestations should be identified and treated before initiating stepwise diagnostic evaluation of dyskalemias. Divalent ion deficiencies such as hypocalcemia, hypomagnesemia and hypophosphatemia should be identified and corrected, since they are associated with increased adverse events among critically ill patients. Copyright © 2010 The Korean Society of Electrolyte Metabolism. | - |
dc.format.extent | 10 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 전해질고혈압연구회 | - |
dc.title | Fluid and electrolyte disturbances in critically ill patients | - |
dc.title.alternative | Fluid and Electrolyte Disturbances in Critically Ill Patients | - |
dc.type | Article | - |
dc.identifier.doi | 10.5049/EBP.2010.8.2.72 | - |
dc.identifier.bibliographicCitation | Electrolyte and Blood Pressure, v.8, no.2, pp 72 - 81 | - |
dc.identifier.kciid | ART001518379 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-80051754105 | - |
dc.citation.endPage | 81 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 72 | - |
dc.citation.title | Electrolyte and Blood Pressure | - |
dc.citation.volume | 8 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Hyperkalemia | - |
dc.subject.keywordAuthor | Hypernatremia | - |
dc.subject.keywordAuthor | Hypocalcemia | - |
dc.subject.keywordAuthor | Hypokalemia | - |
dc.subject.keywordAuthor | Hyponatremia | - |
dc.subject.keywordAuthor | Hypophosphatemia | - |
dc.subject.keywordAuthor | Intensive care | - |
dc.subject.keywordPlus | amphotericin B | - |
dc.subject.keywordPlus | beta adrenergic receptor blocking agent | - |
dc.subject.keywordPlus | bicarbonate | - |
dc.subject.keywordPlus | calcium | - |
dc.subject.keywordPlus | calcium chloride | - |
dc.subject.keywordPlus | cholinergic receptor | - |
dc.subject.keywordPlus | electrolyte | - |
dc.subject.keywordPlus | glucagon | - |
dc.subject.keywordPlus | gluconate calcium | - |
dc.subject.keywordPlus | heparin | - |
dc.subject.keywordPlus | hydrocortisone | - |
dc.subject.keywordPlus | infusion fluid | - |
dc.subject.keywordPlus | insulin | - |
dc.subject.keywordPlus | lactulose | - |
dc.subject.keywordPlus | lithium | - |
dc.subject.keywordPlus | loop diuretic agent | - |
dc.subject.keywordPlus | magnesium | - |
dc.subject.keywordPlus | nonsteroid antiinflammatory agent | - |
dc.subject.keywordPlus | phosphate | - |
dc.subject.keywordPlus | potassium | - |
dc.subject.keywordPlus | potassium sparing diuretic agent | - |
dc.subject.keywordPlus | sodium | - |
dc.subject.keywordPlus | sodium chloride | - |
dc.subject.keywordPlus | suxamethonium | - |
dc.subject.keywordPlus | thiazide diuretic agent | - |
dc.subject.keywordPlus | trimethoprim | - |
dc.subject.keywordPlus | vasopressin | - |
dc.subject.keywordPlus | acute kidney failure | - |
dc.subject.keywordPlus | adverse outcome | - |
dc.subject.keywordPlus | brain edema | - |
dc.subject.keywordPlus | brain injury | - |
dc.subject.keywordPlus | calcium blood level | - |
dc.subject.keywordPlus | calcium transport | - |
dc.subject.keywordPlus | clinical feature | - |
dc.subject.keywordPlus | continuous renal replacement therapy | - |
dc.subject.keywordPlus | critically ill patient | - |
dc.subject.keywordPlus | diabetes insipidus | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | disease severity | - |
dc.subject.keywordPlus | diuresis | - |
dc.subject.keywordPlus | electrolyte disturbance | - |
dc.subject.keywordPlus | fluid resuscitation | - |
dc.subject.keywordPlus | glomerulus filtration rate | - |
dc.subject.keywordPlus | heart failure | - |
dc.subject.keywordPlus | heart ventricle arrhythmia | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hyperkalemia | - |
dc.subject.keywordPlus | hypernatremia | - |
dc.subject.keywordPlus | hypocalcemia | - |
dc.subject.keywordPlus | hypokalemia | - |
dc.subject.keywordPlus | hypomagnesemia | - |
dc.subject.keywordPlus | hyponatremia | - |
dc.subject.keywordPlus | hypophosphatemia | - |
dc.subject.keywordPlus | hypotension | - |
dc.subject.keywordPlus | hypovolemia | - |
dc.subject.keywordPlus | intensive care unit | - |
dc.subject.keywordPlus | metabolic acidosis | - |
dc.subject.keywordPlus | multiple organ failure | - |
dc.subject.keywordPlus | organ perfusion | - |
dc.subject.keywordPlus | oxygen saturation | - |
dc.subject.keywordPlus | papilledema | - |
dc.subject.keywordPlus | patient care | - |
dc.subject.keywordPlus | peripheral edema | - |
dc.subject.keywordPlus | phosphate blood level | - |
dc.subject.keywordPlus | potassium excretion | - |
dc.subject.keywordPlus | potassium transport | - |
dc.subject.keywordPlus | randomized controlled trial (topic) | - |
dc.subject.keywordPlus | renal replacement therapy | - |
dc.subject.keywordPlus | respiratory alkalosis | - |
dc.subject.keywordPlus | respiratory failure | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | seizure | - |
dc.subject.keywordPlus | sodium absorption | - |
dc.subject.keywordPlus | sodium blood level | - |
dc.subject.keywordPlus | sodium urine level | - |
dc.subject.keywordPlus | tachycardia | - |
dc.subject.keywordPlus | tetany | - |
dc.subject.keywordPlus | treatment response | - |
dc.subject.keywordPlus | ultrafiltration | - |
dc.subject.keywordPlus | urine volume | - |
dc.subject.keywordPlus | vitamin D deficiency | - |
dc.subject.keywordPlus | water absorption | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kciCandi | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.